Inhibition of SHIP to enhance stem cell harvest and transplantation
AssigneeUniversity of South Florida
InventorsCaroline Desponts, Joseph Wahle, John Ninos, William Kerr
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of South Florida
InventorsCaroline Desponts, Joseph Wahle, John Ninos, William Kerr
Estimating the term…
The instant invention teaches the inhibition of SHIP expression, or function, for the increased efficacy of autologous stem cell transplants. In another embodiment, interference with SHIP function can be used to temporarily expand and mobilize the hematopoietic stem cell compartment to assist with leukapheresis, to promote hematopoietic recovery after myeloablation treatments, to deplete target stem cell clones (such a leukemic clones and other tumor stem cell types), and to deplete, or damage, the repopulating ability of the endogenous hematopoietic stem cell pool in order to allow transplanted hematopoietic stem cells to better home and engraft and to promote in vivo expansion and mobilization of other organ-specific stem cell populations (e.g., mesenchymal, mammary).
A method of increasing the yield of stem cells in a patient, in vivo, for autologous transplantation, comprising the steps of:
A method of increasing the yield of stem cells from a patient, ex vivo, for autologous transplantation, comprising the steps of:
A non-invasive method for harvesting stem cells from blood, comprising the steps of;
A non-invasive method of promoting recovery of a stem cell population in a patient comprising the step of administering SHIP inhibitor to the patient.
A method of reducing the population of target cells comprising the step of administering an effective amount of SHIP inhibitor to a patient.
Dependencies are inferred from the claim text.